Laboratory products manufacturer and supplier Medline has announced that it is now a direct distributor for Epredia, a member of PHC Group. Epredia is a global leader in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics and tissue diagnostics.
With its new status as distributor, Medline can offer laboratories and customers across the continuum of care access to anatomical pathology products from Epredia, thus expanding Medline's extensive portfolio of products, devices and equipment.
"Medline is confidently and quickly growing our presence in the laboratory space," said Nicole Krpan, General Manager of Laboratory at Medline. "And, we are excited to augment our product offering with Epredia – whose legacy and brands are deeply embedded and always in demand in the market."
Increasing complexity of cancer diagnostics means laboratories are under increasing pressure to speed up processes and reduce costs. Laboratories in acute and non-acute care settings around the world have looked to Epredia for solutions that improve the laboratory workflow to help pathologists deliver quality results and timely diagnoses.
"We are excited to begin this partnership with Medline as we serve our mutual customers in the anatomical pathology market space," said Larry Cook, Vice President of Epredia Commercial Operations - Americas. "With Medline's extensive distribution network combined with Epredia's products, commercial and service support, this partnership strengthens our focus cantered on 'improving lives by enhancing cancer diagnostics' for patients, researchers, and clinical laboratories in the US market."